April 25, 2016
The new indication for Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets; dasabuvir tablets) will allow it to be used for patients with genotype 1b chronic hepatitis C and compensated cirrhosis. 
April 25, 2016

The drug is a synthetic androgen available in 100-count bottles of 10-mg tablets. 

April 22, 2016
Allergan on Thursday announced that it had acquired topical dermatology company Topokine Therapeutics, which develops medicine for fat reduction.
April 20, 2016

Dr. Reddy’s Laboratories subsidiary Promius Pharma announced Tuesday that its Zembrace SymTouch (sumatriptan injection) is now commercially available in the United Stated. 

April 20, 2016

The drug is indicated to treat attention deficit/hyperactivity disorder (ADHD) in children aged 6 years and older.

April 14, 2016
The app is available through the iTunes App Store for iOS devices and the Google Play store for Android devices. 
April 14, 2016

DSN examines chain pharmacy, including in-depth coverage of specialty pharmacy, orphan drugs and biosimilars, in this multi-page report.

 

April 13, 2016

Biologic medications — nine of which were among the Food and Drug Administration’s approvals in 2015 — constitute a big portion of the specialty market.

April 13, 2016

The legislation, advocated by both retail pharmacy and the pharma industry, would advance collaboration among health and enforcement authorities to achieve drug abuse solutions that maintain patients’ legitimate access to medications.

April 13, 2016

It’s no secret that the category of drugs drawing the most attention — and money — in recent years has been specialty pharmacy.

April 12, 2016

A new report from Accenture is shedding light on a new focus on the part of pharmaceutical companies: investing in patient-centered capabilities and services.

April 12, 2016

The company said it uses web-based pharmacy benefit system MERLIN, which has 16 integrated modules that can aid in personalizing service for each client.

April 11, 2016

Mike Kelly has been in the industry for almost 30 years, and joins Adapt Pharma— maker of Narcan Nasal Spray (naloxone HCl) — from Covis Pharmaceuticals, where he was CEO and a member of its board. 

April 11, 2016

California pharmacists are authorized to furnish oral, transdermal, vaginal and Depo injection forms of prescription birth control under a new law that took effect April 8. 

April 11, 2016

AbbVie’s Venclexta received priority review, accelerated approval and the breakthrough therapy designation from the FDA. 

April 11, 2016

When implementation of Walgreens' naloxone program is complete, naloxone will be available without a prescription in more than 5,800 of Walgreens nearly 8,200 stores.

April 7, 2016

The letter points out that copay increases place financial burdens on TRICARE beneficiaries and restrict patient access. In addition, restricting patient access could adversely impact medication compliance and actually increase health costs. 

April 6, 2016

The combined company would bring to market oncology therapies, men’s and women’s health therapeutics and consumer health products. 

April 6, 2016

Hospira, now a Pfizer company, entered into an agreement with Celltrion and Celltrion Healthcare in 2009 for several potential biosimilar products, including the recently-approved Inflectra.

April 6, 2016

In connection with the termination of the merger agreement, Pfizer has agreed to pay Allergan $150 million for reimbursement of expenses associated with the transaction.

April 5, 2016

The partnership is aimed at accelerating several of CutisPharma's products in development toward FDA approval. 

April 5, 2016

Descovy has a similar antiviral efficacy to Gilead’s Viread (tenofovir disoproxil fumarate), but contains one-tenth the dose of tenofovir as Viread, the company said. 

April 4, 2016

The study found that Walgreens pharmacy patients who used a multi-faceted medication adherence program had a 3% higher medication adherence rate and lower healthcare costs than those who use other pharmacies.

April 1, 2016

However, flu activity is still relatively high across Wyoming, Montana and Kentucky, according to the report.